Also found in: Wikipedia.
KNSAKoninklijke Nederlandse Schutters Associatie (Dutch: Royal Netherlands Shooters Association)
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(Nasdaq: KNSA) ('Kiniksa'), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients with significant unmet medical need, today announced a collaboration with the Myocarditis Foundation in support of patients affected by pericarditis with heart muscle inflammation.
* Kiniksa Pharmaceuticals (NASDAQ: KNSA) shares moved up 0.18% on Tuesday's session after setting a new 52-week low of $10.70 to begin trading.
* Kiniksa Pharmaceuticals (NASDAQ: KNSA) shares made a new 52-week low of $11.45 on Tuesday.